C

CTI Biopharma Corp
F:CEPS

Watchlist Manager
CTI Biopharma Corp
F:CEPS
Watchlist
Price: 28 EUR
Market Cap: 3.7B EUR

Wall Street
Price Targets

CEPS Price Targets Summary
CTI Biopharma Corp

There are no price targets for CEPS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
CTI Biopharma Corp Competitors:
Price Targets
MSB
Mesoblast Ltd
65% Upside
NBIX
Neurocrine Biosciences Inc
29% Upside
BOLT
Bolt Biotherapeutics Inc
514% Upside
TGTX
TG Therapeutics Inc
10% Upside
ZYME
Zymeworks Inc
75% Upside
NVAX
Novavax Inc
136% Upside
KRYS
Krystal Biotech Inc
51% Upside
HPHA
Heidelberg Pharma AG
176% Upside

Revenue
Forecast

Revenue Estimate
CTI Biopharma Corp

For the last 8 years the compound annual growth rate for CTI Biopharma Corp's revenue is -1%. The projected CAGR for the next 4 years is -35%.

-1%
Past Growth
-35%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CTI Biopharma Corp

Operating Income forecast
is not available for
CTI Biopharma Corp

Net Income
Forecast

Net Income Estimate
CTI Biopharma Corp

Net Income forecast
is not available for
CTI Biopharma Corp
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CEPS's stock price target?
Not Available

CEPS doesn't have any price targets made by Wall Street professionals.

What is CTI Biopharma Corp's Revenue forecast?
Projected CAGR
-35%

For the last 8 years the compound annual growth rate for CTI Biopharma Corp's revenue is -1%. The projected CAGR for the next 4 years is -35%.

Back to Top